0000899243-20-019545.txt : 20200717 0000899243-20-019545.hdr.sgml : 20200717 20200717175037 ACCESSION NUMBER: 0000899243-20-019545 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200715 FILED AS OF DATE: 20200717 DATE AS OF CHANGE: 20200717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schamroth Michael CENTRAL INDEX KEY: 0001375385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19879 FILM NUMBER: 201034553 MAIL ADDRESS: STREET 1: 191 MEADOWVIEW AVENUE CITY: HEWLETT STATE: NY ZIP: 11557 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-15 0 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375385 Schamroth Michael C/O BIOSPECIFICS TECHNOLOGIES CORP. 2 RIGHTER PKWY, DE CORPORATE CENTER II WILMINGTON DE 19803 1 0 0 0 Common Stock, $0.001 par value 2020-07-15 4 A 0 1726 0.00 A 117616 D Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. The restricted stock units generally will vest in full on the first anniversary of the date of grant. /s/ Michael Schamroth by Carl A. Valenstein, attorney- in-fact 2020-07-17